Clinical Trial Details
EORTC-40902
Back to Clinical Trials Database
Randomized phase III study of ELF (etoposide + 5-FU + Leucovorin) versus 5-FU continuous infusion + Cisplatin versus FAMTX (Methotrexate + 5-FU combined with adriamycin) in advanced gastric cancer
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 28-Jun-1991 Date Step1 close: 11-Apr-1995 |
| Data management at EORTC | Yes |
| Design |
Phase 3 Randomized open label |
| Targeted Sample size | EORTC Groups: 400 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/ |
| NCT number |
